Literature DB >> 23730508

Hepatosplenic alpha/beta T-cell lymphoma masquerading as cirrhosis.

Jonah Cohen1, Eduardo Hariton, Darshan Kothari, German A Pihan, Simon C Robson.   

Abstract

A 59-year-old man with diabetes mellitus, prior hepatitis B infection and recently diagnosed cirrhosis with prior Babesiosis presented to our institution from an outside hospital with six months of worsening abdominal pain, myalgias and fevers. On admission, physical examination revealed jaundice, hepatosplenomegaly and diffuse lymphadenopathy. Laboratory investigations demonstrated mild anemia, thrombocytopenia, hyperbilirubinemia and elevated lactate dehydrogenase. Tests for human immunodeficiency virus, and active Babesia microti infection were negative, however Epstein-Barr virus DNA by quantitative PCR was markedly elevated. CT scan revealed features suggestive of a cirrhotic liver without focal mass lesions as well as massive splenomegaly with axillary, retroperitoneal and inguinal lymphadenopathy. Bone marrow and lymph node biopsies were obtained which ultimately revealed hepatosplenic T-cell lymphoma. The patient's initial liver biopsy from five months prior to presentation was re-evaluated by our institution's pathologists. Histologic analysis showed hepatic sinusoidal and portal infiltration of atypical lymphocytes morphologically identical to those present on the more recently excised lymph node tissue. The hepatic sinusoidal lymphoid cells were strongly positive for CD2, CD3 and CD5 whereas CD4, CD8 stained only minor subsets of the T cells. Subsequent flow cytometric immunophenotypying of peripheral blood identified T-cell receptor alpha/beta positive cells that lacked CD4 and CD8 (double negative alpha/beta T cells). Given the established bone marrow involvement, he was diagnosed with stage IV disease and treated with chemotherapy. His clinical course involved multiple hospitalizations complicated by hyponatremia, neutropenic fevers and pulmonary emboli. Following his fourth cycle of chemotherapy, he developed worsening liver failure and expired approximately three months after initial diagnosis of lymphoma. Hepatosplenic lymphoma of alpha/beta T cells is a rare malignancy with largely unclear risk factors and varied clinical presentations. Notably, diffuse infiltration of liver parenchyma is a prominent feature and the disease can mimic cirrhosis clinically as well as radiographically. Early recognition of this aggressive lymphoma is important and should be considered in the evaluation of patients in whom the etiology of cirrhosis remains in question.

Entities:  

Keywords:  Babesia microti; Liver cirrhosis; T-cell lymphoma; autoimmune hepatitis

Year:  2013        PMID: 23730508      PMCID: PMC3635184          DOI: 10.3978/j.issn.2078-6891.2013.017

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  26 in total

1.  In vitro and in vivo effects of 2'-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignancies.

Authors:  D Aldinucci; D Poletto; V Zagonel; M Rupolo; M Degan; P Nanni; V Gattei; A Pinto
Journal:  Br J Haematol       Date:  2000-07       Impact factor: 6.998

2.  Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes.

Authors:  G K Przybylski; H Wu; W R Macon; J Finan; D G Leonard; R E Felgar; J A DiGiuseppe; P C Nowell; S H Swerdlow; M E Kadin; M A Wasik; K E Salhany
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

3.  Hepatosplenic gammadelta T cell lymphoma: a diagnostic pitfall.

Authors:  Bart J Veldt; Carel Meijers; Pieter E Zondervan; Robert A de Man
Journal:  J Hepatol       Date:  2003-09       Impact factor: 25.083

4.  Diffuse desmoplastic metastatic breast cancer simulating cirrhosis with severe portal hypertension: a case of "pseudocirrhosis".

Authors:  David A Sass; Kenneth Clark; Dana Grzybicki; Mordechai Rabinovitz; Thomas A Shaw-Stiffel
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.199

5.  Hepatosplenic alphabeta T cell lymphoma.

Authors:  Yuya Nagai; Kazuhiro Ikegame; Minako Mori; Daichi Inoue; Takaharu Kimura; Sonoko Shimoji; Katsuhiro Togami; Sumie Tabata; Masayuki Kurata; Yukihiro Imai; Akiko Matsushita; Kenichi Nagai; Hiroyasu Ogawa; Takayuki Takahashi
Journal:  Int J Clin Oncol       Date:  2010-03-10       Impact factor: 3.402

6.  Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas.

Authors:  W R Macon; N B Levy; P J Kurtin; K E Salhany; M Y Elkhalifa; T T Casey; F E Craig; C L Vnencak-Jones; M L Gulley; J P Park; J B Cousar
Journal:  Am J Surg Pathol       Date:  2001-03       Impact factor: 6.394

7.  Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules.

Authors:  K Ohshima; S Haraoka; N Harada; T Kamimura; J Suzumiya; M Kanda; C Kawasaki; M Sugihara; M Kikuchi
Journal:  Histopathology       Date:  2000-02       Impact factor: 5.087

8.  Hepatic failure and death due to new onset T cell lymphoma.

Authors:  Ekta Gupta; James E Rose; Joel E Straughen; Laura E Lamps; Kevin W Olden
Journal:  J Gastrointest Cancer       Date:  2011-09

9.  Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment.

Authors:  G S Falchook; F Vega; N H Dang; F Samaniego; M A Rodriguez; R E Champlin; C Hosing; S Verstovsek; B Pro
Journal:  Ann Oncol       Date:  2009-02-23       Impact factor: 32.976

Review 10.  Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients.

Authors:  Karim Belhadj; Felix Reyes; Jean-Pierre Farcet; Herve Tilly; Christian Bastard; Regis Angonin; Eric Deconinck; Frederic Charlotte; Veronique Leblond; Eric Labouyrie; Pierre Lederlin; Jean-Francois Emile; Beatrice Delmas-Marsalet; Bertrand Arnulf; Elie-Serge Zafrani; Philippe Gaulard
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

View more
  1 in total

1.  The imaging conundrum of hepatic lymphoma revisited.

Authors:  S Rajesh; Kalpana Bansal; Binit Sureka; Yashwant Patidar; Chhagan Bihari; Ankur Arora
Journal:  Insights Imaging       Date:  2015-10-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.